Search
for

    Sort by

    Research 901–930 of 1000+

    1. Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves Proceedings of the National Academy of Sciences · 2005 · 319 citations
    2. Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children Paediatric Respiratory Reviews · 2004 · 42 citations
    3. Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia International Journal of Infectious Diseases · 2021 · 38 citations
    4. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice Journal of Clinical Investigation · 2003 · 21 citations
    5. Epidermal dysplasia and <i>Malassezia</i> infection in two West Highland White Terrier siblings: an inherited skin disorder or reaction to severe <i>Malassezia</i> infection? Veterinary dermatology · 2001 · 17 citations
    6. Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata 2015 · 14 citations
    7. The relationship among androgens, insulin resistanceand ghrelin polymorphisms in post-adolescent malepatients with severe acne vulgaris Advances in Dermatology and Allergology · 2020 · 10 citations
    8. Maintenance effect of a once-weekly regimen of a Selenium Disulfide-based shampoo in moderate-to-severe scalp seborrheic dermatitis after initial treatment with topical corticosteroid/salicylic acid European Journal of Dermatology · 2023 · 7 citations
    9. P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss PloS one · 2022 · 5 citations
    10. Scalp Hair Regrowth Is Associated With Improvements in Health-Related Quality of Life and Psychological Symptoms in Patients With Severe Alopecia Areata: Results From Two Randomized Controlled Trials SKIN The Journal of Cutaneous Medicine · 2023 · 4 citations
    11. 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2024 · 2 citations
    12. Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies Journal of the American Academy of Dermatology · 2024 · 2 citations
    13. 41824 Palmoplantar psoriasis complete clearance is achieved rapidly and sustained with ixekizumab treatment in adult and pediatric patients with moderate-to-severe plaque psoriasis Journal of the American Academy of Dermatology · 2023 · 2 citations
    14. Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data Aesthetic Surgery Journal · 2023 · 2 citations
    15. Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19 Frontiers in Nutrition · 2022 · 2 citations
    16. A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol Skin Health and Disease · 2025 · 1 citations
    17. Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’” Journal of The American Academy of Dermatology · 2020 · 1 citations
    18. Regrowth of Upper Eyelid Eyelashes After Making a Surgical Incision on the Upper Eyelid in a Case of Severe Alopecia Areata Ophthalmic plastic and reconstructive surgery · 2013 · 1 citations
    19. Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to &lt;12 years of Age With Severe Alopecia Areata SKIN The Journal of Cutaneous Medicine · 2026
    20. Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata Mendeley Data · 2025
    21. Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata Mendeley Data · 2025
    22. Table 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx Figshare · 2025
    23. Supplementary file 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx Figshare · 2025
    24. Safety and Clinical Efficacy of KūlarisTM, an Herbal Supplement for Mild to Severe Acne Vulgaris – A 12-Week Randomized, Double Blind, Placebo-Controlled Study Clinical Cosmetic and Investigational Dermatology · 2025
    25. P075 A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata British Journal of Dermatology · 2025
    26. Comparing the Efficacy of Weekly Azathioprine Pulse versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata Pakistan Journal of Health Sciences · 2025
    27. Caracterización de signos cutáneos y sus anexos, en niños menores de 5 años con desnutrición severa Revista Digital de Postgrado · 2025
    28. Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib Dermatology and Therapy · 2024
    29. Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib Dermatology and Therapy · 2024
    30. Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials JEADV Clinical Practice · 2024